Sign inGet started

Schutz James J

Insider CIK 1367079 · OCLS Chief Operating Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-153,571— $0184,516SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-1530,000— $067,733SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-154,285— $0167,733SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-155,357— $0172,018SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-151,428— $0177,375SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-153,928— $0178,803SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-151,785— $0182,731SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-1567,733— $00SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-155,271— $0188,087SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-1520,000— $0147,733SEC↗
SNOA Sonoma Pharmaceuticals, In H Expire deriv2019-01-142019-01-1550,000— $097,733SEC↗
SNOA Sonoma Pharmaceuticals, In A Award deriv2018-07-202018-07-2467,733— $0193,358SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2018-03-082018-03-082,473$3.99 $9.9K35,858SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2018-01-022018-01-0317,211— $033,385SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-11-302017-12-04345$4.95 $1.7K16,174SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-11-292017-11-29400$5.03 $2.0K15,829SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-11-242017-11-27254$5.05 $1.3K15,429SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-08-102017-08-10929$5.46 $5.1K15,175SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-06-292017-06-302,406— $014,246SEC↗
SNOA Sonoma Pharmaceuticals, In A Award deriv2017-04-032017-04-0530,000— $0133,658SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-03-032017-03-07104$6.75 $70211,840SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2017-03-032017-03-07696$6.78 $4.7K11,736SEC↗
SNOA Sonoma Pharmaceuticals, In P Buy2016-12-082016-12-081,000$4.88 $4.9K11,040SEC↗
OCLS Oculus Innovative Sciences A Award deriv2016-11-302016-12-0250,000— $0103,658SEC↗
OCLS Oculus Innovative Sciences A Award2016-11-302016-12-023,535$4.81 $17.0K10,040SEC↗
OCLS Oculus Innovative Sciences P Buy2016-08-152016-08-161,328$3.66 $4.9K6,505SEC↗
OCLS Oculus Innovative Sciences P Buy2016-02-252016-02-295,000$1.00 $5.0K25,885SEC↗
OCLS Oculus Innovative Sciences P Buy2014-11-172014-11-176,285$1.78 $11.2K20,885SEC↗
OCLS Oculus Innovative Sciences A Award deriv2013-09-192013-09-20100,000— $0232,298SEC↗
OCLS Oculus Innovative Sciences P Buy2013-08-162013-08-195,100$2.35 $12.0K14,600SEC↗
OCLS Oculus Innovative Sciences P Buy2012-11-092012-11-0911,400$0.80 $9.1K65,000SEC↗
OCLS Oculus Innovative Sciences P Buy2012-11-092012-11-09100$0.80 $8053,600SEC↗
OCLS Oculus Innovative Sciences P Buy2012-11-092012-11-091,000$0.78 $78066,500SEC↗
OCLS Oculus Innovative Sciences P Buy2012-11-092012-11-09500$0.80 $40065,500SEC↗
OCLS Oculus Innovative Sciences A Award deriv2012-08-242012-08-27150,000— $01,147,000SEC↗
OCLS Oculus Innovative Sciences A Award deriv2012-03-072012-03-09187,500— $0997,000SEC↗